Indrayani Biotech Ltd. Announces Rights Issue of ₹49.90 Crore with 5:7 Rights Entitlement Ratio

Indrayani Biotech Ltd. has announced the outcome of the Rights Issue Committee Meeting held on 09-04-2026. The committee has approved the terms of the Rights Issue, which includes the issuance of 3,25,25,897 equity shares at a price of ₹15 per share (including a premium of ₹5 per share), amounting to ₹49.90 crore. The record date for the Rights Issue is Tuesday, 28-04-2026, and the Rights Issue period is from 27-05-2026 to 25-06-2026. The rights entitlement ratio is 5 Rights Equity Shares for every 7 fully paid-up equity shares held by the Eligible Equity Shareholders as on the record date. The company has made arrangements with NSDL and CDSL for the credits of the rights entitlements in dematerialized form in the demat account of the Eligible Equity Shareholders.